Dr. Robert Mark Burke, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 503 Pearl Lee Rd, Ripton, VT 05766 Phone: 802-989-7082 |
News Archive
A new Harris Poll suggests that the flu vaccine used before last winter may have been less effective than the vaccines used in some previous years.
Athersys, Inc. announced today the publication of a key study in the October issue of Experimental Neurology conducted by researchers at Athersys, the University of Texas Medical School, the Michael E. DeBakey Institute for Comparative Cardiovascular Science and Biomedical Devices, and Texas A&M University.
A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.
Pfizer Inc. and Medivation, Inc. today announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine) in patients with Alzheimer's disease (AD). In the CONNECTION trial, dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function.
› Verified 3 days ago